Medtronic plc Cost of Revenue
Medtronic plc (MDT) reported Cost of Revenue of $3.42 billion for the 3-month period ending 2026-07-31, per its 10-Q filed 2026-09-03.
Financial Statements › Expense Statement
us-gaap:CostOfGoodsAndServicesSold · last filed 2026-09-03
- Medtronic plc cost of goods and services sold for the quarter ending 2026-07-31 was $3.42B, a 13.83% increase year-over-year.
- Medtronic plc cost of goods and services sold for the quarter ending 2026-04-24 was $3.40B, a 7.98% increase year-over-year.
- Medtronic plc cost of goods and services sold for the quarter ending 2026-01-23 was $3.26B, a 17.34% increase year-over-year.
- Medtronic plc cost of goods and services sold for the quarter ending 2025-10-24 was $3.06B, a 3.90% increase year-over-year.
- Medtronic plc cost of goods and services sold for fiscal 2026 was $12.72B, a 9.36% increase from fiscal 2025.
- Medtronic plc cost of goods and services sold for fiscal 2025 was $11.63B, a 3.71% increase from fiscal 2024.
- Medtronic plc cost of goods and services sold for fiscal 2024 was $11.22B, a 4.64% increase from fiscal 2023.
- Medtronic plc cost of goods and services sold for fiscal 2023 was $10.72B, a 5.66% increase from fiscal 2022.
| Period end | Cost of Goods and Services Sold 3 month | Cost of Goods and Services Sold 3 month as first filed | Cost of Goods and Services Sold 6 month | Cost of Goods and Services Sold 6 month as first filed | Cost of Goods and Services Sold 9 month | Cost of Goods and Services Sold 9 month as first filed | Cost of Goods and Services Sold 12 month | Cost of Goods and Services Sold 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-07-31 | $3.42B 10-Q · filed 2026-09-03 | $6.81B derived: sum of 2 quarters · filed 2026-09-03 | $10.07B derived: sum of 3 quarters · filed 2026-09-03 | $13.14B derived: sum of 4 quarters · filed 2026-09-03 | ||||
| 2026-04-24 | $3.40B derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-18 | $6.66B derived: sum of 2 quarters · filed 2026-06-18 | $9.72B derived: sum of 3 quarters · filed 2026-06-18 | $12.72B 10-K · filed 2026-06-18 | ||||
| 2026-01-23 | $3.26B 10-Q · filed 2026-02-24 | $6.32B derived: sum of 2 quarters · filed 2026-02-24 | $9.32B 10-Q · filed 2026-02-24 | $12.47B derived: sum of 4 quarters · filed 2026-09-03 | ||||
| 2025-10-24 | $3.06B 10-Q · filed 2025-11-25 | $6.06B 10-Q · filed 2025-11-25 | $9.21B derived: sum of 3 quarters · filed 2026-09-03 | $11.99B derived: sum of 4 quarters · filed 2026-09-03 | ||||
| 2025-07-25 | $3.00B 10-Q · filed 2026-09-03 | $6.15B derived: sum of 2 quarters · filed 2026-09-03 | $8.93B derived: sum of 3 quarters · filed 2026-09-03 | $11.87B derived: sum of 4 quarters · filed 2026-09-03 | ||||
| 2025-04-25 | $3.15B derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-18 | $5.93B derived: sum of 2 quarters · filed 2026-06-18 | $8.87B derived: sum of 3 quarters · filed 2026-06-18 | $11.63B 10-K · filed 2026-06-18 | ||||
| 2025-01-24 | $2.78B 10-Q · filed 2026-02-24 | $5.72B derived: sum of 2 quarters · filed 2026-02-24 | $8.48B 10-Q · filed 2026-02-24 | $11.53B derived: sum of 4 quarters · filed 2026-06-18 | ||||
| 2024-10-25 | $2.95B 10-Q · filed 2025-11-25 | $5.71B 10-Q · filed 2025-11-25 | $8.75B derived: sum of 3 quarters · filed 2026-06-18 | $11.53B derived: sum of 4 quarters · filed 2026-06-18 | ||||
| 2024-07-26 | $2.76B 10-Q · filed 2025-08-26 | $5.80B derived: sum of 2 quarters · filed 2026-06-18 | $8.59B derived: sum of 3 quarters · filed 2026-06-18 | $11.35B derived: sum of 4 quarters · filed 2026-06-18 | ||||
| 2024-04-26 | $3.04B derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-18 | $5.83B derived: sum of 2 quarters · filed 2026-06-18 | $8.59B derived: sum of 3 quarters · filed 2026-06-18 | $11.22B 10-K · filed 2026-06-18 | ||||
| 2024-01-26 | $2.78B 10-Q · filed 2025-02-25 | $5.54B derived: sum of 2 quarters · filed 2025-02-25 | $8.17B 10-Q · filed 2025-02-25 | $11.15B derived: sum of 4 quarters · filed 2025-06-20 | ||||
| 2023-10-27 | $2.76B 10-Q · filed 2024-11-26 | $5.39B 10-Q · filed 2024-11-26 | $8.37B derived: sum of 3 quarters · filed 2025-06-20 | $11.06B derived: sum of 4 quarters · filed 2025-06-20 | ||||
| 2023-07-28 | $2.63B 10-Q · filed 2024-08-27 | $5.61B derived: sum of 2 quarters · filed 2025-06-20 | $8.30B derived: sum of 3 quarters · filed 2025-06-20 | $10.83B derived: sum of 4 quarters · filed 2025-06-20 | ||||
| 2023-04-28 | $2.98B derived: 10-K 12 month − 10-Q 9 month · filed 2025-06-20 | $5.67B derived: sum of 2 quarters · filed 2025-06-20 | $8.20B derived: sum of 3 quarters · filed 2025-06-20 | $10.72B 10-K · filed 2025-06-20 | ||||
| 2023-01-27 | $2.69B 10-Q · filed 2024-02-27 | $5.22B derived: sum of 2 quarters · filed 2024-02-27 | $7.74B 10-Q · filed 2024-02-27 | $10.33B derived: sum of 4 quarters · filed 2024-06-20 | ||||
| 2022-10-28 | $2.54B 10-Q · filed 2023-11-30 | $5.05B 10-Q · filed 2023-11-30 | $7.64B derived: sum of 3 quarters · filed 2024-06-20 | $10.10B derived: sum of 4 quarters · filed 2024-06-20 | ||||
| 2022-07-29 | $2.52B 10-Q · filed 2023-08-31 | $5.11B derived: sum of 2 quarters · filed 2024-06-20 | $7.57B derived: sum of 3 quarters · filed 2024-06-20 | $10.06B derived: sum of 4 quarters · filed 2024-06-20 | ||||
| 2022-04-29 | $2.59B derived: 10-K 12 month − 10-Q 9 month · filed 2024-06-20 | $5.05B derived: sum of 2 quarters · filed 2024-06-20 | $7.55B derived: sum of 3 quarters · filed 2024-06-20 | $10.14B 10-K · filed 2024-06-20 | ||||
| 2022-01-28 | $2.46B 10-Q · filed 2023-03-01 | $4.96B derived: sum of 2 quarters · filed 2023-03-01 | $7.55B 10-Q · filed 2023-03-01 | $10.21B derived: sum of 4 quarters · filed 2023-06-22 | ||||
| 2021-10-29 | $2.50B 10-Q · filed 2022-12-01 | $5.09B 10-Q · filed 2022-12-01 | $7.75B derived: sum of 3 quarters · filed 2023-06-22 | $10.37B derived: sum of 4 quarters · filed 2023-06-22 | ||||
| 2021-07-30 | $2.60B 10-Q · filed 2022-09-01 | $5.25B derived: sum of 2 quarters · filed 2023-06-22 | $7.87B derived: sum of 3 quarters · filed 2023-06-22 | $10.58B derived: sum of 4 quarters · filed 2023-06-22 | ||||
| 2021-04-30 | $2.65B derived: 10-K 12 month − 10-Q 9 month · filed 2023-06-22 | $5.27B derived: sum of 2 quarters · filed 2023-06-22 | $7.98B derived: sum of 3 quarters · filed 2023-06-22 | $10.48B 10-K · filed 2023-06-22 | ||||
| 2021-01-29 | $2.62B 10-Q · filed 2022-03-03 | $5.33B derived: sum of 2 quarters · filed 2022-03-03 | $7.83B 10-Q · filed 2022-03-03 | $10.10B derived: sum of 4 quarters · filed 2022-06-23 | ||||
| 2020-10-30 | $2.71B 10-Q · filed 2021-12-02 | $5.21B 10-Q · filed 2021-12-02 | $7.47B derived: sum of 3 quarters · filed 2022-06-23 | $9.87B derived: sum of 4 quarters · filed 2022-06-23 | ||||
| 2020-07-31 | $2.50B 10-Q · filed 2021-09-02 | $4.77B derived: sum of 2 quarters · filed 2022-06-23 | $7.17B derived: sum of 3 quarters · filed 2022-06-23 | $9.56B derived: sum of 4 quarters · filed 2022-06-23 | ||||
| 2020-04-24 | $2.26B derived: 10-K 12 month − 10-Q 9 month · filed 2022-06-23 | $4.66B derived: sum of 2 quarters · filed 2022-06-23 | $7.06B derived: sum of 3 quarters · filed 2022-06-23 | $9.42B 10-K · filed 2022-06-23 | ||||
| 2020-01-24 | $2.40B 10-Q · filed 2021-03-05 | $4.79B derived: sum of 2 quarters · filed 2021-03-05 | $7.16B 10-Q · filed 2021-03-05 | $9.64B derived: sum of 4 quarters · filed 2021-06-25 | ||||
| 2019-10-25 | $2.39B 10-Q · filed 2020-12-03 | $4.76B 10-Q · filed 2020-12-03 | $7.24B derived: sum of 3 quarters · filed 2021-06-25 | $9.51B derived: sum of 4 quarters · filed 2021-06-25 | ||||
| 2019-07-26 | $2.37B 10-Q · filed 2020-09-03 | $4.85B derived: sum of 2 quarters · filed 2021-06-25 | $7.11B derived: sum of 3 quarters · filed 2021-06-25 | $9.32B derived: sum of 4 quarters · filed 2021-06-25 | ||||
| 2019-04-26 | $2.48B derived: 10-K 12 month − 10-Q 9 month · filed 2021-06-25 | $4.75B derived: sum of 2 quarters · filed 2021-06-25 | $6.95B derived: sum of 3 quarters · filed 2021-06-25 | $9.15B 10-K · filed 2021-06-25 | ||||
| 2019-01-25 | $2.27B 10-Q · filed 2020-02-28 | $4.47B derived: sum of 2 quarters · filed 2020-02-28 | $6.67B 10-Q · filed 2020-02-28 | $9.07B derived: sum of 4 quarters · filed 2020-06-19 | ||||
| 2018-10-26 | $2.20B 10-Q · filed 2019-12-03 | $4.41B 10-Q · filed 2019-12-03 | $6.80B derived: sum of 3 quarters · filed 2020-06-19 | $9.00B derived: sum of 4 quarters · filed 2020-06-19 | ||||
| 2018-07-27 | $2.20B 10-Q · filed 2019-08-30 | $4.60B derived: sum of 2 quarters · filed 2020-06-19 | $6.80B derived: sum of 3 quarters · filed 2020-06-19 | $8.92B derived: sum of 4 quarters · filed 2020-06-19 | ||||
| 2018-04-27 | $2.40B derived: 10-K 12 month − 10-Q 9 month · filed 2020-06-19 | $4.59B derived: sum of 2 quarters · filed 2020-06-19 | $6.71B derived: sum of 3 quarters · filed 2020-06-19 | $9.07B 10-K · filed 2020-06-19 | $9.05B 10-K · filed 2018-06-22 | |||
| 2018-01-26 | $2.19B 10-Q · filed 2019-03-01 | $2.19B 10-Q · filed 2018-03-02 | $4.32B derived: sum of 2 quarters · filed 2019-03-01 | $6.67B 10-Q · filed 2019-03-01 | $6.66B 10-Q · filed 2018-03-02 | $9.11B derived: sum of 4 quarters · filed 2019-06-21 | ||
| 2017-10-27 | $2.12B 10-Q · filed 2018-11-29 | $2.12B 10-Q · filed 2017-12-04 | $4.47B 10-Q · filed 2018-11-29 | $4.47B 10-Q · filed 2017-12-04 | $6.91B derived: sum of 3 quarters · filed 2019-06-21 | $9.18B derived: sum of 4 quarters · filed 2019-06-21 | ||
| 2017-07-28 | $2.35B 10-Q · filed 2018-08-31 | $2.35B 10-Q · filed 2017-09-01 | $4.79B derived: sum of 2 quarters · filed 2019-06-21 | $7.06B derived: sum of 3 quarters · filed 2019-06-21 | $9.38B derived: sum of 4 quarters · filed 2019-06-21 | |||
| 2017-04-28 | $2.44B derived: 10-K 12 month − 10-Q 9 month · filed 2019-06-21 | $4.71B derived: sum of 2 quarters · filed 2019-06-21 | $7.03B derived: sum of 3 quarters · filed 2019-06-21 | $9.29B 10-K · filed 2019-06-21 | $9.29B 10-K · filed 2017-06-27 | |||
| 2017-01-27 | $2.27B 10-Q · filed 2018-03-02 | $4.59B derived: sum of 2 quarters · filed 2018-03-02 | $6.86B 10-Q · filed 2018-03-02 | $9.22B derived: sum of 4 quarters · filed 2018-06-22 | ||||
| 2016-10-28 | $2.33B 10-Q · filed 2017-12-04 | $4.59B 10-Q · filed 2017-12-04 | $6.95B derived: sum of 3 quarters · filed 2018-06-22 | $9.09B derived: sum of 4 quarters · filed 2018-06-22 | ||||
| 2016-07-29 | $2.26B 10-Q · filed 2017-09-01 | $4.62B derived: sum of 2 quarters · filed 2018-06-22 | $6.76B derived: sum of 3 quarters · filed 2018-06-22 | $8.95B derived: sum of 4 quarters · filed 2018-06-22 | ||||
| 2016-04-29 | $2.36B derived: 10-K 12 month − 10-Q 9 month · filed 2018-06-22 | $4.50B derived: sum of 2 quarters · filed 2018-06-22 | $6.69B derived: sum of 3 quarters · filed 2018-06-22 | $9.14B 10-K · filed 2018-06-22 | ||||
| 2016-01-29 | $2.14B 10-Q · filed 2017-03-03 | $4.32B derived: sum of 2 quarters · filed 2017-03-03 | $6.78B 10-Q · filed 2017-03-03 | $9.71B derived: sum of 4 quarters · filed 2017-06-27 | ||||
| 2015-10-30 | $2.18B 10-Q · filed 2016-12-05 | $4.64B 10-Q · filed 2016-12-05 | $7.57B derived: sum of 3 quarters · filed 2017-06-27 | $8.70B derived: sum of 4 quarters · filed 2017-06-27 | ||||
| 2015-07-31 | $2.46B 10-Q · filed 2016-09-07 | $5.39B derived: sum of 2 quarters · filed 2017-06-27 | $6.52B derived: sum of 3 quarters · filed 2017-06-27 | $7.66B derived: sum of 4 quarters · filed 2017-06-27 | ||||
| 2015-04-24 | $2.93B derived: 10-K 12 month − 10-Q 9 month · filed 2017-06-27 | $4.06B derived: sum of 2 quarters · filed 2017-06-27 | $5.20B derived: sum of 3 quarters · filed 2017-06-27 | $6.31B 10-K · filed 2017-06-27 | ||||
| 2015-01-23 | $1.13B 10-Q · filed 2016-03-09 | $2.27B derived: sum of 2 quarters · filed 2016-03-09 | $3.38B 10-Q · filed 2016-03-09 | |||||
| 2014-10-24 | $1.14B 10-Q · filed 2015-12-09 | $2.25B 10-Q · filed 2015-12-09 | ||||||
| 2014-07-25 | $1.10B 10-Q · filed 2015-09-09 | |||||||
| 2014-04-25 | $4.33B 10-K · filed 2016-06-28 | |||||||
| 2013-04-26 | $4.13B 10-K · filed 2015-06-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Integer Holdings Corp (ITGR) | United States | $4.289B | 25.17 |
| LivaNova PLC (LIVN) | $4.158B | 24.01 | |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B |